Aurora Cannabis (ACB) Projected to Post Earnings on Thursday

Aurora Cannabis (NASDAQ:ACB) is anticipated to issue its Q4 2026 results before the market opens on Thursday, June 11th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $54.42 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2026 earning report page for the latest details on the call scheduled for Thursday, June 11, 2026 at 8:00 AM ET.

Aurora Cannabis Stock Down 2.6%

Aurora Cannabis stock opened at $3.42 on Thursday. The firm has a market cap of $209.78 million, a price-to-earnings ratio of -3.17 and a beta of 0.53. The company has a current ratio of 3.06, a quick ratio of 1.48 and a debt-to-equity ratio of 0.06. Aurora Cannabis has a 12 month low of $3.07 and a 12 month high of $6.66. The stock has a fifty day simple moving average of $3.45 and a two-hundred day simple moving average of $3.89.

Analysts Set New Price Targets

Several research firms recently commented on ACB. Weiss Ratings upgraded Aurora Cannabis from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 1st. Wall Street Zen upgraded shares of Aurora Cannabis from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 9th. One analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold”.

Hedge Funds Weigh In On Aurora Cannabis

Hedge funds and other institutional investors have recently modified their holdings of the company. Jones Financial Companies Lllp boosted its stake in shares of Aurora Cannabis by 9,615.6% in the 1st quarter. Jones Financial Companies Lllp now owns 52,270 shares of the company’s stock worth $229,000 after buying an additional 51,732 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Aurora Cannabis by 4.1% during the first quarter. Goldman Sachs Group Inc. now owns 743,903 shares of the company’s stock valued at $3,266,000 after acquiring an additional 29,099 shares during the last quarter. Engineers Gate Manager LP bought a new position in Aurora Cannabis in the second quarter valued at about $68,000. Tidal Investments LLC boosted its position in Aurora Cannabis by 6.0% in the second quarter. Tidal Investments LLC now owns 1,509,483 shares of the company’s stock worth $6,400,000 after purchasing an additional 86,045 shares during the last quarter. Finally, Headlands Technologies LLC purchased a new position in Aurora Cannabis in the second quarter worth about $66,000. 47.63% of the stock is owned by institutional investors.

Aurora Cannabis Company Profile

Aurora Cannabis Inc (NASDAQ: ACB) is a Canadian licensed producer of medical and consumer cannabis products headquartered in Edmonton, Alberta. Established in 2013, the company operates under Health Canada’s regulations to cultivate, process and distribute a range of cannabis-based offerings. Since its initial public listing in 2017, Aurora has grown into one of the country’s largest growers by cultivation capacity and production output.

The company’s core business spans the cultivation of dried flower, the extraction of cannabis oils and the development of value-added products such as softgels, capsules and topical treatments.